Whole-cell modeling of E. coli colonies enables quantification of single-cell heterogeneity in antibiotic responses

PLoS Comput Biol. 2023 Jun 16;19(6):e1011232. doi: 10.1371/journal.pcbi.1011232. eCollection 2023 Jun.

Abstract

Antibiotic resistance poses mounting risks to human health, as current antibiotics are losing efficacy against increasingly resistant pathogenic bacteria. Of particular concern is the emergence of multidrug-resistant strains, which has been rapid among Gram-negative bacteria such as Escherichia coli. A large body of work has established that antibiotic resistance mechanisms depend on phenotypic heterogeneity, which may be mediated by stochastic expression of antibiotic resistance genes. The link between such molecular-level expression and the population levels that result is complex and multi-scale. Therefore, to better understand antibiotic resistance, what is needed are new mechanistic models that reflect single-cell phenotypic dynamics together with population-level heterogeneity, as an integrated whole. In this work, we sought to bridge single-cell and population-scale modeling by building upon our previous experience in "whole-cell" modeling, an approach which integrates mathematical and mechanistic descriptions of biological processes to recapitulate the experimentally observed behaviors of entire cells. To extend whole-cell modeling to the "whole-colony" scale, we embedded multiple instances of a whole-cell E. coli model within a model of a dynamic spatial environment, allowing us to run large, parallelized simulations on the cloud that contained all the molecular detail of the previous whole-cell model and many interactive effects of a colony growing in a shared environment. The resulting simulations were used to explore the response of E. coli to two antibiotics with different mechanisms of action, tetracycline and ampicillin, enabling us to identify sub-generationally-expressed genes, such as the beta-lactamase ampC, which contributed greatly to dramatic cellular differences in steady-state periplasmic ampicillin and was a significant factor in determining cell survival.

MeSH terms

  • Ampicillin / pharmacology
  • Anti-Bacterial Agents* / pharmacology
  • Bacteria
  • Drug Resistance, Microbial / genetics
  • Escherichia coli* / physiology
  • Humans
  • Microbial Sensitivity Tests
  • Tetracycline / pharmacology
  • beta-Lactamases

Substances

  • Anti-Bacterial Agents
  • Ampicillin
  • Tetracycline
  • beta-Lactamases